KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $128.9 million.

  • Ginkgo Bioworks Holdings' Operating Expenses fell 1067.31% to $128.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $528.7 million, marking a year-over-year decrease of 3795.75%. This contributed to the annual value of $786.8 million for FY2024, which is 2948.94% down from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Operating Expenses stood at $128.9 million, which was down 1067.31% from $115.1 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Operating Expenses' 5-year high stood at $1.8 billion during Q4 2021, with a 5-year trough of $101.2 million in Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $215.9 million (2024), whereas its average is $374.4 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Operating Expenses skyrocketed by 198449.39% in 2021 and then plummeted by 8204.54% in 2022.
  • Ginkgo Bioworks Holdings' Operating Expenses (Quarter) stood at $1.8 billion in 2021, then tumbled by 82.05% to $329.1 million in 2022, then tumbled by 35.33% to $212.9 million in 2023, then tumbled by 30.73% to $147.5 million in 2024, then dropped by 12.61% to $128.9 million in 2025.
  • Its last three reported values are $128.9 million in Q3 2025, $115.1 million for Q2 2025, and $137.3 million during Q1 2025.